View the PDF

Includes: After curative-intent treatment, prostate cancer recurrence is still an unmet need, Cancer’s ‘rogue DNA’ relies on two proteins to prevent and repair breaks, Researchers uncover dual role of B7-H3 in prostate tumor immune suppression, AI-Powered Pathology Biomarker Predicts Survival and Treatment Benefit in Metastatic Hormone-Sensitive Prostate Cancer, First commercial procedures performed with Zenflow Spring for BPH, Use of MRI before prostate biopsies increases sharply across U.S. hospitals, and more.